244 related articles for article (PubMed ID: 28340565)
1. u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression.
Ciavarella S; Laurenzana A; De Summa S; Pilato B; Chillà A; Lacalamita R; Minoia C; Margheri F; Iacobazzi A; Rana A; Merchionne F; Fibbi G; Del Rosso M; Guarini A; Tommasi S; Serratì S
BMC Cancer; 2017 Mar; 17(1):215. PubMed ID: 28340565
[TBL] [Abstract][Full Text] [Related]
2. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynold LM
Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
[TBL] [Abstract][Full Text] [Related]
3. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
4. Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.
Kanemaru A; Yamamoto K; Kawaguchi M; Fukushima T; Lin CY; Johnson MD; Camerer E; Kataoka H
Int J Cancer; 2017 Jan; 140(1):130-141. PubMed ID: 27615543
[TBL] [Abstract][Full Text] [Related]
5. Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system.
Killeen SD; Wang JH; Andrews EJ; Redmond HP
Br J Cancer; 2009 May; 100(10):1589-602. PubMed ID: 19436306
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
[TBL] [Abstract][Full Text] [Related]
7. A cleavage-resistant urokinase plasminogen activator receptor exhibits dysregulated cell-surface clearance.
Nieves EC; Manchanda N
J Biol Chem; 2010 Apr; 285(17):12595-603. PubMed ID: 20177061
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
[TBL] [Abstract][Full Text] [Related]
9. [Study of the effect of TF/FVIIa complex on the expression of u-PAR mRNA in human ovarian cancer].
Fang J; Wei WN; Xia LH; Song SJ
Zhonghua Xue Ye Xue Za Zhi; 2004 Mar; 25(3):143-6. PubMed ID: 15182581
[TBL] [Abstract][Full Text] [Related]
10. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.
Fibbi G; Pucci M; Grappone C; Pellegrini G; Salzano R; Casini A; Milani S; Del Rosso M
Hepatology; 1999 Mar; 29(3):868-78. PubMed ID: 10051491
[TBL] [Abstract][Full Text] [Related]
11. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM
Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677
[TBL] [Abstract][Full Text] [Related]
13. The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.
Paciucci R; Torà M; Díaz VM; Real FX
Oncogene; 1998 Feb; 16(5):625-33. PubMed ID: 9482108
[TBL] [Abstract][Full Text] [Related]
14. CD146 attenuation in cancer-associated fibroblasts promotes pancreatic cancer progression.
Zheng B; Ohuchida K; Chijiiwa Y; Zhao M; Mizuuchi Y; Cui L; Horioka K; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M; Tanaka M
Mol Carcinog; 2016 Nov; 55(11):1560-1572. PubMed ID: 26373617
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
Chung HW; Wen Y; Ahn JJ; Moon HS; Polan ML
J Clin Endocrinol Metab; 2001 Mar; 86(3):1332-40. PubMed ID: 11238529
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct.
Roldán-Olarte M; García DC; Jiménez-Díaz M; Valdecantos PA; Miceli DC
Anim Reprod Sci; 2012 Dec; 136(1-2):90-9. PubMed ID: 23103014
[TBL] [Abstract][Full Text] [Related]
17. Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.
Zheng MH; Fan Y; Panicker A; Smith A; Robertson T; Wysocki S; Robbins P; Papadimitriou JM; Wood DJ
Am J Pathol; 1995 Dec; 147(6):1559-66. PubMed ID: 7495280
[TBL] [Abstract][Full Text] [Related]
18. Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of p38 MAPK.
Hecht M; Heider U; Kaiser M; von Metzler I; Sterz J; Sezer O
Br J Haematol; 2007 Aug; 138(4):446-58. PubMed ID: 17593251
[TBL] [Abstract][Full Text] [Related]
19. Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase-induced tyrosine phosphorylation.
Mirshahi SS; Lounes KC; Lu H; Pujade-Lauraine E; Mishal Z; Bénard J; Bernadou A; Soria C; Soria J
FEBS Lett; 1997 Jul; 411(2-3):322-6. PubMed ID: 9271229
[TBL] [Abstract][Full Text] [Related]
20. Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.
Shiomi H; Eguchi Y; Tani T; Kodama M; Hattori T
Am J Pathol; 2000 Feb; 156(2):567-75. PubMed ID: 10666386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
